This webinar, recorded in July 2025, will provide an overview of current practices and advancements in heart failure and heart transplantation, and how to best serve these specific patient populations to maximize health outcomes. The practical management of these patients within the cardiac rehab setting will be discussed, including assessment, exercise, nutrition, psychosocial needs, medication management, blood glucose monitoring, infection control, rejection, and long-term self-monitoring.

This free recorded webinar series, sponsored by Novo Nordisk Inc., is tailored to multidisciplinary cardiac rehabilitation professionals, and will consist of three, 60-minute webinar presentations addressing weight management and guideline directed care in cardiovascular disease.

In this session, the presenter will discuss what e-cigarettes are, who is using e-cigarettes and why, and what current evidence we have regarding the health impact of e-cigarette use.

In this session, presenters will provide an overview of tobacco treatment within the rehab setting, and discuss how to utilizes tools and resources developed from the Tips From Former Smokers® campaign.

This webinar, recorded in June 2025, the presenters will provide an overview of sleep apnea epidemiology, clinical presentation and cardiovascular implications. Additionally, they will also discuss how sleep disorders may impact cardiac rehabilitation outcomes.

This webinar, recorded in May 2025, will update CR practitioners to factors associated with increased cardiovascular risk, patient assessment strategies, advances in diabetes-related technology, and recommendations for improving participation outcomes and optimizing glycemic control around exercise.

During this presentation, recorded as a live webinar in May 2025, Dr. Lavie will review the adverse effects of obesity and cardiovascular disease risk factors and to increase the prevalence of cardiovascular disease.

This session, recorded in April 2025, explores the evolution and impact of psychocardiology, highlighting its emergence as a critical field addressing the intersection of cardiovascular disease (CVD) and psychological distress. Participants will gain insights into key psychosocial stressors affecting CVD patients and learn how to apply screening tools and both pharmacologic and non-pharmacologic interventions to improve patient outcomes. Additionally, the session will emphasize the integration of psychosocial care into cardiac and pulmonary rehabilitation, underscoring its essential role in the early detection and management of mental health conditions to enhance overall cardiovascular and pulmonary health.

Frailty is associated with higher mortality, disability, and hospitalization in the cardiac population. It is critical to identify frail and vulnerable patients and adapt their assessment and intervention plan within the frame of primary and secondary prevention of CVDs.

This presentation will address that vast variations of the placement of Cardiac and Pulmonary Rehab Programs in an organizational structure and how these structures can negative and/or positively impact program operations and sustainability.